Amy Leader
Overview
Explore the profile of Amy Leader including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
243
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bradt J, Leader A, Worster B, Myers-Coffman K, Bryl K, Biondo J, et al.
Psychooncology
. 2024 Oct;
33(10):e70005.
PMID: 39450934
Objective: To improve mechanistic understanding, this randomized controlled trial examined anxiety, mood, emotional support, and pain-related self-efficacy as mediators of music therapy for pain management in people with advanced cancer....
2.
Doherty M, Heintz J, Leader A, Wittenburg D, Ben-Shalom Y, Jacoby J, et al.
Front Psychol
. 2023 Dec;
14:1320743.
PMID: 38152561
[This corrects the article DOI: 10.3389/fpsyg.2023.1179320.].
3.
Shenton L, Perera U, Leader A, Klassen A
Integr Cancer Ther
. 2023 Sep;
22:15347354231198072.
PMID: 37694880
Purpose: Cancer patients who remain tobacco users have poorer outcomes, including increased mortality and decreased treatment tolerance; however, cessation post-diagnosis is challenging. Our formative research explored cessation-related perspectives among patients...
4.
Doherty M, Heintz J, Leader A, Wittenburg D, Ben-Shalom Y, Jacoby J, et al.
Front Psychol
. 2023 Aug;
14:1245878.
PMID: 37546474
[This corrects the article DOI: 10.3389/fpsyg.2023.1179320.].
5.
Doherty M, Heintz J, Leader A, Wittenberg D, Ben-Shalom Y, Jacoby J, et al.
Front Psychol
. 2023 Jun;
14:1179320.
PMID: 37275728
Cancer-related financial hardship (i.e., financial toxicity) has been associated with anxiety and depression, greater pain and symptom burden, treatment nonadherence, and mortality. Out-of-pocket healthcare costs and lost income are primary...
6.
Worster B, Waldman L, Garber G, Zhan T, Lopez A, Trachtenberg O, et al.
Cancer Med
. 2022 Oct;
12(3):2842-2849.
PMID: 36210751
Introduction: Telehealth (TH) utilization in cancer care prior to COVID-19 was variable. Research highlights disparities in access determined by socioeconomic factors including education, income, race, and age. In response to...
7.
Loeb S, Cheng H, Leader A, Gross L, Nolasco T, Byrne N, et al.
Contemp Clin Trials
. 2022 Jun;
119:106821.
PMID: 35710085
Background: Germline testing has an increasingly important role in prostate cancer care. However, a relative shortage of genetic counselors necessitates alternate strategies for delivery of pre-test education for germline testing....
8.
Zavodnick J, Wickersham A, Petok A, Worster B, Leader A
J Addict Dis
. 2022 Feb;
40(4):527-537.
PMID: 35133217
Background: Prescription Drug Monitoring Programs (PDMPs) have shown impacts on a number of opioid-related outcomes but their role in clinician emotional experience of opioid prescribing has not been studied. Objectives:...
9.
Lombardo J, Ko K, Shimada A, Nelson N, Wright C, Chen J, et al.
Cancer Causes Control
. 2022 Jan;
33(4):559-582.
PMID: 34984592
Purpose: A disparity exists in cancer screening rates for the Sexual and Gender Minority (SGM) community. We sought to understand the perceptions and baseline knowledge of cancer screening among SGM...
10.
Jeurkar C, Leiby B, Banks J, Leader A, Rudolph S, Mateja G, et al.
Transplant Cell Ther
. 2021 Apr;
27(4):327.e1-327.e11.
PMID: 33836876
Previous analyses of the effects of race and socioeconomic status (SES) on outcomes after hematopoietic stem cell transplantation (HSCT) have suggested that minority populations and those in disadvantaged groups have...